ABOS
Price
$2.16
Change
-$0.01 (-0.46%)
Updated
Dec 24 closing price
Capitalization
130.84M
95 days until earnings call
Intraday BUY SELL Signals
RVPH
Price
$0.28
Change
-$0.04 (-12.50%)
Updated
Dec 24 closing price
Capitalization
32.48M
88 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABOS vs RVPH

Header iconABOS vs RVPH Comparison
Open Charts ABOS vs RVPHBanner chart's image
Acumen Pharmaceuticals
Price$2.16
Change-$0.01 (-0.46%)
Volume$97.98K
Capitalization130.84M
Reviva Pharmaceuticals Holdings
Price$0.28
Change-$0.04 (-12.50%)
Volume$14.55M
Capitalization32.48M
ABOS vs RVPH Comparison Chart in %
ABOS
Daily Signal:
Gain/Loss:
RVPH
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ABOS vs. RVPH commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Hold and RVPH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (ABOS: $2.16 vs. RVPH: $0.28)
Brand notoriety: ABOS and RVPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 46% vs. RVPH: 203%
Market capitalization -- ABOS: $130.84M vs. RVPH: $32.48M
ABOS [@Biotechnology] is valued at $130.84M. RVPH’s [@Biotechnology] market capitalization is $32.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileRVPH’s FA Score has 1 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • RVPH’s FA Score: 1 green, 4 red.
According to our system of comparison, both ABOS and RVPH are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 7 TA indicator(s) are bullish while RVPH’s TA Score has 5 bullish TA indicator(s).

  • ABOS’s TA Score: 7 bullish, 3 bearish.
  • RVPH’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ABOS is a better buy in the short-term than RVPH.

Price Growth

ABOS (@Biotechnology) experienced а +5.37% price change this week, while RVPH (@Biotechnology) price change was -54.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Reported Earning Dates

ABOS is expected to report earnings on Mar 30, 2026.

RVPH is expected to report earnings on Mar 23, 2026.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABOS($131M) has a higher market cap than RVPH($32.5M). ABOS YTD gains are higher at: 25.581 vs. RVPH (-84.641). RVPH has higher annual earnings (EBITDA): -22.71M vs. ABOS (-128.99M). ABOS has more cash in the bank: 127M vs. RVPH (13.2M). RVPH has less debt than ABOS: RVPH (113K) vs ABOS (30.8M). ABOS (0) and RVPH (0) have equivalent revenues.
ABOSRVPHABOS / RVPH
Capitalization131M32.5M403%
EBITDA-128.99M-22.71M568%
Gain YTD25.581-84.641-30%
P/E RatioN/AN/A-
Revenue00-
Total Cash127M13.2M962%
Total Debt30.8M113K27,257%
FUNDAMENTALS RATINGS
RVPH: Fundamental Ratings
RVPH
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
10
SEASONALITY SCORE
1..100
10

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABOSRVPH
RSI
ODDS (%)
Bullish Trend 7 days ago
70%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 16 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ABOS
Daily Signal:
Gain/Loss:
RVPH
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPOK13.030.10
+0.77%
Spok Holdings
DARE2.170.01
+0.46%
Dare Bioscience Inc.
TKR86.02-0.07
-0.08%
Timken Company (The)
BUD63.83-0.12
-0.19%
Anheuser-Busch INBEV SA/NV
BFC128.36-1.07
-0.83%
Bank First Corp

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with BEAM. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
-0.46%
BEAM - ABOS
45%
Loosely correlated
+1.33%
CELC - ABOS
44%
Loosely correlated
+0.25%
SYRE - ABOS
41%
Loosely correlated
-0.54%
CRBU - ABOS
40%
Loosely correlated
+3.61%
CRSP - ABOS
39%
Loosely correlated
+0.44%
More

RVPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVPH has been loosely correlated with ALT. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if RVPH jumps, then ALT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVPH
1D Price
Change %
RVPH100%
-13.48%
ALT - RVPH
50%
Loosely correlated
-0.50%
INM - RVPH
29%
Poorly correlated
-2.38%
GOSS - RVPH
29%
Poorly correlated
+4.72%
INDP - RVPH
29%
Poorly correlated
+35.90%
ABOS - RVPH
27%
Poorly correlated
-0.46%
More